Coinbase Founder’s Longevity Startup Triples in Value
The Surge in Longevity Biotech NewLimit, a San Francisco-based biotechnology startup co-founded by Coinbase CEO Brian Armstrong and former research scientist Blake Byers, has reached a valuation of $3.1 billion following a successful funding round. The company, which focuses on epigenetic reprogramming to treat age-related diseases, is now preparing to initiate clinical trials for its…